ORIGINAL RESEARCH article

Front. Public Health

Sec. Aging and Public Health

Volume 13 - 2025 | doi: 10.3389/fpubh.2025.1583339

A systematic analysis of Alzheimer's disease and other dementias burden in Asia from 1990 to 2021 with projection to 2036: based on the global burden of disease 2021 data

Provisionally accepted
Ziyang  HeZiyang He1Haoqin  ZhangHaoqin Zhang1Guishan  HuGuishan Hu1Yinan  QiaoYinan Qiao1Can  YinCan Yin1Jianqiao  LiJianqiao Li1Hong  LinHong Lin1Anguo  WuAnguo Wu1Dalian  QinDalian Qin1Betty  Yuen-Kwan LawBetty Yuen-Kwan Law2Guangqiang  HuGuangqiang Hu1*Lu  YuLu Yu1*
  • 1Southwest Medical University, Luzhou, Sichuan, China
  • 2Macau University of Science and Technology, Taipa, Macao, Macao, SAR China

The final, formatted version of the article will be published soon.

Background: With global aging, Alzheimer's disease (AD) and other dementias have emerged as significant health threats to the elderly, garnering considerable attention regarding their impact on public health. Despite the substantial burden of dementia in Asia, targeted research remains limited. This study aims to assess the current burden, future trends, risk factors, and inequalities in Asia.The GBD 2021 study was utilized to evaluate the numbers and age-standardized rates (ASRs) of prevalence, mortality, and disability-adjusted life-years (DALYs) of AD and other dementias from 1990 to 2021. Joinpoint regression analysis was performed to assess the trends during this period, while the Autoregressive Integrated Moving Average (ARIMA) model was employed to predict future trends. Additionally, the relationship between disease burden and sociodemographic index (SDI) was also analyzed. Results: In 2021, Asia experienced a 250.44% increase in prevalent cases, a 297.34% rise in mortality, and a 249.54% surge in DALYs for AD and other dementias compared to 1990. Meanwhile, the age-standardized prevalence rate, age-standardized mortality rate, and agestandardized DALY rate also exhibited varying degrees of rise from 1990 to 2021. Demographically, the disease burden was higher in women and those aged 65 and above. Regionally, the burden was highest in East Asia and relatively low in South and Central Asia. Nationally, China, India, Japan, and Indonesia reported the most cases. Over the next 15 years, the age-standardized prevalence rate in Asia is expected to peak in 2028 before declining, while the age-standardized mortality rate is anticipated to keep rising. An overall " V " shaped association was found between sociodemographic index (SDI) and the age-standardized DALY rate in Asia. Only smoking, high fasting plasma glucose (FPG), and high BMI were identified as causal risk factors within the GBD framework.The burden of AD and other dementias in Asia has significantly increased over the past three decades and is expected to persistently impact Asian populations, particularly in developing countries experiencing rapid demographic shifts. Women and the elderly should be a focus of attention. It is imperative to implement targeted prevention and intervention strategies, enhance chronic disease management, and control risk factors.

Keywords: Alzherimer's disease and other dementia, Global Burden of Disease (GBD), Risk factors, Prevalence, Mortality, Disability-adjusted life years (DALYs)

Received: 25 Feb 2025; Accepted: 12 May 2025.

Copyright: © 2025 He, Zhang, Hu, Qiao, Yin, Li, Lin, Wu, Qin, Law, Hu and Yu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Guangqiang Hu, Southwest Medical University, Luzhou, Sichuan, China
Lu Yu, Southwest Medical University, Luzhou, Sichuan, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.